INMD News and Press, InMode Ltd. From 09/29/21

Applied UV (NASDAQ:AUVI) +41% on KES Science & Technology assets acquisition GeoVax Labs (NASDAQ:GOVX) +24% after deal for clinical-stage cancer program NuCana (NASDAQ:NCNA) +15% receives fast track designation from the U.S. Food and Drug Administration for Acelar...

Gainers: Sonoma Pharmaceuticals (NASDAQ:SNOA) +33%, Evelo Biosciences (NASDAQ:EVLO) +12%, ZIVO Bioscience (NASDAQ:ZIVO) +12%, Viridian Therapeutics (NASDAQ:VRDN) +7%, Harpoon Therapeutics (NASDAQ:HARP) +7%. Losers: Altimmune (NASDAQ:ALT) -20%, ...

Five-year average YoY revenue growth of 72.50%, EBITDA growth of 338.00%, and EPS growth of 653.94% are jaw-dropping. Profitability metrics (EBIT margin at 44.16% and Net Income margin at 44.34%) are impressive. The market is underestimating their revenue growth potential from new...

Top Health Care Stocks To Watch Right Now In a world where a global pandemic has been overshadowing our daily lives, health care stocks would often be top picks in the stock market. After a year and a half, many people would expect that we could return to our normal lives. Howev...

Shares of InMode (NASDAQ: INMD) , a provider of devices that harness radiofrequency energy for cosmetic surgical procedures, are up 20% this week as of the close on Thursday afternoon. Image source: Getty Images. The primary news seems to be an announcement last Friday that ...

Ultimate Growth Investing offers our best growth ideas in a specially-curated service aiming for 5x to 10x returns over five years. We built this service to form an active, helpful, and inclusive community of growth investors and journey together through the ups and downs of the marke...

InMode Ltd. Announces 2-for-1 Share Split PR Newswire YOKNEAM, Israel , Sept. 17, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode" or the "Company"), a leading global provider of innovative medical technologies, today announced a two-for-one (2:1) s...

Anything can happen in the short term, so it's folly to say that a stock is a sure thing for a quick double. Nonetheless, these Fool.com contributors are bullish on these three healthcare stocks, and there are reasons for short-term optimism. Read more to find out why we think Novavax...

InMode has consistently executed its business flawlessly with exceptional margins. The company has dedicated management with a long-term outlook. The company’s technology has many other possibilities which are currently in development. InMode is operating in a very simi...

InMode to Participate in Upcoming Virtual Conferences in September PR Newswire YOKNEAM, Israel , Sept. 9, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) , a leading global provider of innovative medical technologies, today announced that management will...